TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope,
President and Chief Executive Officer, and Joseph P. Slattery, Executive
Vice President and Chief Financial Officer, will present at two upcoming
investor conferences.
-
Stifel 2015 Healthcare Conference on Tuesday, November 17, 2015 at
3:00 pm Eastern Time at the Palace Hotel in New York.
-
Canaccord Genuity Medical Technologies and Diagnostics Forum on
Thursday, November 19, 2015 at 11:20 am Eastern Time at the Westin
Grand Central in New York.
To access the live audio webcast or archived recording for either
conference, use the following link http://ir.transenterix.com/events.cfm.
The replay for both presentations will also be available on the
company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the development and
commercialization of the SurgiBot™ System, a single-port, robotically
enhanced laparoscopic surgical platform, and the commercialization of
ALF-X®, a multi-port robotic system that brings the advantages of
robotic surgery to patients while enabling surgeons with innovative
technology such as haptic feedback and eye tracking camera control. The
SurgiBot System is not yet available for sale in any market. The ALF-X
has been granted a CE Mark but is not available for sale in the US. For
more information, visit the TransEnterix website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005474/en/
Copyright Business Wire 2015